Literature DB >> 17541548

Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome".

Erwin Ista1, Monique van Dijk, Claudia Gamel, Dick Tibboel, Matthijs de Hoog.   

Abstract

BACKGROUND: Prolonged administration of benzodiazepines and/or opioids to children in a pediatric intensive care unit (PICU) may induce physiological dependence and withdrawal symptoms.
OBJECTIVE: We reviewed the literature for relevant contributions on the nature of these withdrawal symptoms and on availability of valid scoring systems to assess the extent of symptoms.
METHODS: The databases PubMed, CINAHL, and Psychinfo (1980-June 2006) were searched using relevant key terms.
RESULTS: Symptoms of benzodiazepine and opioid withdrawal can be classified in two groups: central nervous system effects and autonomic dysfunction. However, symptoms of the two types show a large overlap for benzodiazepine and opioid withdrawal. Symptoms of gastrointestinal dysfunction in the PICU population have been described for opioid withdrawal only. Six assessment tools for withdrawal symptoms are used in children. Four of these have been validated for neonates only. Two instruments are available to specifically determine withdrawal symptoms in the PICU: the Sedation Withdrawal Score (SWS) and the Opioid Benzodiazepine Withdrawal Scale (OBWS). The OBWS is the only available assessment tool with prospective validation; however, the sensitivity is low.
CONCLUSIONS: Withdrawal symptoms for benzodiazepines and opioids largely overlap. A sufficiently sensitive instrument for assessing withdrawal symptoms in PICU patients needs to be developed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541548     DOI: 10.1007/s00134-007-0696-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  48 in total

1.  Assessment and treatment of abstinence in the infant of the drug-dependent mother.

Authors:  L P Finnegan; R E Kron; J F Connaughton; J P Emich
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

Review 2.  Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens.

Authors:  A Shafer
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

3.  Opioid and benzodiazepine withdrawal syndrome in adult burn patients.

Authors:  C Brown; R Albrecht; H Pettit; T McFadden; C Schermer
Journal:  Am Surg       Date:  2000-04       Impact factor: 0.688

4.  Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children.

Authors:  J D Tobias
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

5.  Acute benzodiazepine withdrawal syndrome after midazolam infusions in children.

Authors:  M R Sury; I Billingham; G N Russell; C S Hopkins; R Thornington; E Vivori
Journal:  Crit Care Med       Date:  1989-03       Impact factor: 7.598

6.  Consensus guidelines on sedation and analgesia in critically ill children.

Authors:  Stephen Playfor; Ian Jenkins; Carolyne Boyles; Imti Choonara; Gerald Davies; Tim Haywood; Gillian Hinson; Anton Mayer; Neil Morton; Tanya Ralph; Andrew Wolf
Journal:  Intensive Care Med       Date:  2006-05-13       Impact factor: 17.440

7.  Adverse reactions to the withdrawal of opioids and benzodiazepines in paediatric intensive care.

Authors:  F A Carnevale; C Ducharme
Journal:  Intensive Crit Care Nurs       Date:  1997-08       Impact factor: 3.072

Review 8.  Opioid tolerance and dependence in infants and children.

Authors:  K J Anand; J H Arnold
Journal:  Crit Care Med       Date:  1994-02       Impact factor: 7.598

9.  Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam.

Authors:  B G van Engelen; J S Gimbrere; L H Booy
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

10.  Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.

Authors:  L S Franck; J Vilardi; D Durand; R Powers
Journal:  Am J Crit Care       Date:  1998-09       Impact factor: 2.228

View more
  19 in total

Review 1.  Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.

Authors:  Kaitlin M Best; Joseph I Boullata; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2015-02       Impact factor: 3.624

2.  Use of methadone for opioid weaning in children: prescribing practices and trends.

Authors:  Kazim Giby; Régis Vaillancourt; Nisha Varughese; Christina Vadeboncoeur; Annie Pouliot
Journal:  Can J Hosp Pharm       Date:  2014-03

3.  Prolonged Dexmedetomidine Infusion and Drug Withdrawal In Critically Ill Children.

Authors:  Astrid S Haenecour; Winnie Seto; Charline M Urbain; Derek Stephens; Peter C Laussen; Corrine R Balit
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

4.  Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: a feasibility study.

Authors:  Sarah H Heil; Diann E Gaalema; Anne M Johnston; Stacey C Sigmon; Gary J Badger; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2012-06-08       Impact factor: 4.492

5.  Sedation Management for Critically Ill Children with Pre-Existing Cognitive Impairment.

Authors:  Kaitlin M Best; Lisa A Asaro; Martha A Q Curley
Journal:  J Pediatr       Date:  2018-12-05       Impact factor: 4.406

6.  Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure.

Authors:  Lauren A Sanlorenzo; William O Cooper; Judith A Dudley; Shannon Stratton; Faouzi I Maalouf; Stephen W Patrick
Journal:  Hosp Pediatr       Date:  2019-07-01

7.  Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation.

Authors:  E D Wildschut; M N Hanekamp; N J Vet; R J Houmes; M J Ahsman; R A A Mathot; S N de Wildt; D Tibboel
Journal:  Intensive Care Med       Date:  2010-05-28       Impact factor: 17.440

8.  Impact of a Standardized Treatment Guideline for Pediatric Iatrogenic Opioid Dependence: A Quality Improvement Initiative.

Authors:  Rima Abdouni; Teri Reyburn-Orne; Tarek H Youssef; Imad Y Haddad; Richard D Gerkin
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

9.  The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.

Authors:  Linda S Franck; Sion Kim Harris; Deborah J Soetenga; June K Amling; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2008-11       Impact factor: 3.624

10.  Construction of the Sophia Observation withdrawal Symptoms-scale (SOS) for critically ill children.

Authors:  Erwin Ista; Monique van Dijk; Matthijs de Hoog; Dick Tibboel; Hugo J Duivenvoorden
Journal:  Intensive Care Med       Date:  2009-04-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.